Company research
Telix Pharmaceuticals Ltd
CIK 2007191Updated Sep 24, 2026
SecuritiesTLPPF · OTC · equityTLX · NASDAQ · adr
TLPPF price & chart
Loading TradingView…
OTC:TLPPF on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Profit or LossUSD | -7,125,000Source | 49,919,000Source | 5,211,000Source |
| Additional Financial Items | |||
| AdjustmentsForCurrentTaxOfPriorPeriodAUD | — | 0Source | 0Source |
| AdjustmentsForDeferredTaxOfPriorPeriodsAUD | — | 0Source | 0Source |
| AdjustmentsForSharebasedPaymentsUSD | 19,350,000Source | 19,660,000Source | 8,786,000Source |
| AdjustmentsForUnrealisedForeignExchangeLossesGainsUSD | -1,926,000Source | -17,317,000Source | 2,124,000Source |
| GeneralAndAdministrativeExpenseUSD | 95,789,000Source | 129,830,000Source | 74,181,000Source |
| GoodwillUSD | 198,988,000Source | — | — |
| IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesUSD | 21,298,000Source | 2,809,000Source | 10,253,000Source |
| InterestPaidClassifiedAsOperatingActivitiesUSD | 13,700,000Source | 4,730,000Source | 785,000Source |
| InterestReceivedClassifiedAsOperatingActivitiesUSD | 5,843,000Source | 10,856,000Source | 1,629,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | 5,237,000Source | 2,015,000Source | 2,222,000Source |
| ProceedsFromBorrowingsClassifiedAsFinancingActivitiesUSD | 529,000Source | 655,938,000Source | 5,756,000Source |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesUSD | 18,084,000Source | 19,710,000Source | 1,115,000Source |
| RepaymentsOfBorrowingsClassifiedAsFinancingActivitiesUSD | 819,000Source | 1,115,000Source | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cost of Goods and Services Sold | — | — | — |
| Total RevenueUSD | 803,794,000Source | 783,207,000Source | 502,547,000Source |
| Additional Financial Items | |||
| ApplicableTaxRatenumber | 0.3Source | — | — |
| AverageEffectiveTaxRatenumber | — | 0.3Source | 0.3Source |
| BasicEarningsLossPerShareUSD per share | -0.02Source | 15.07Source | 1.63Source |
| CurrentTaxExpenseIncomeUSD | 13,994,000Source | 32,422,000Source | 14,357,000Source |
| DeferredTaxExpenseIncomeUSD | -12,135,000Source | -26,285,000Source | -16,481,000Source |
| DeferredTaxExpenseIncomeRecognisedInProfitOrLossUSD | 18,590,000Source | 32,128,000Source | 15,163,000Source |
| DepreciationAndAmortisationExpenseUSD | 21,506,000Source | 8,018,000Source | 6,743,000Source |
| DepreciationRightofuseAssetsUSD | 7,776,000Source | 2,332,000Source | 1,457,000Source |
| DilutedEarningsLossPerShareUSD per share | -0.02Source | 14.46Source | 1.61Source |
| EmployeeBenefitsExpenseUSD | 219,528,000Source | 173,510,000Source | 109,849,000Source |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesUSD | 19,146,000Source | 19,660,000Source | 8,786,000Source |
| FinanceCostsUSD | 40,868,000Source | 36,936,000Source | 13,772,000Source |
| FinanceIncomeUSD | 5,826,000Source | 10,862,000Source | 1,019,000Source |
| GeneralAndAdministrativeExpenseUSD | 95,789,000Source | 129,830,000Source | 74,181,000Source |
| GrossProfitUSD | 426,438,000Source | 509,678,000Source | 314,390,000Source |
| ImpairmentLossRecognisedInProfitOrLossGoodwillUSD | 0Source | 0Source | — |
| ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillUSD | -566,000Source | — | -804,000Source |
| IncomeTaxExpenseContinuingOperationsUSD | 1,859,000Source | 6,137,000Source | -2,124,000Source |
| InterestExpenseUSD | 181,000Source | 82,000Source | 148,000Source |
| InterestExpenseOnLeaseLiabilitiesUSD | 3,637,000Source | 745,000Source | 636,000Source |
| OtherIncomeAUD | — | 442,000Source | 21,000Source |
| ProfessionalFeesExpenseUSD | 16,541,000Source | 17,508,000Source | 12,644,000Source |
| ProfitLossAttributableToOwnersOfParentUSD | -7,125,000Source | 49,919,000Source | 5,211,000Source |
| ProfitLossBeforeTaxUSD | -5,266,000Source | 56,056,000Source | 3,087,000Source |
| ProfitLossFromOperatingActivitiesUSD | 29,776,000Source | 82,130,000Source | 15,840,000Source |
| ResearchAndDevelopmentExpenseUSD | 171,249,000Source | 194,637,000Source | 128,537,000Source |